Hydrofarm appoints Eric Cesari CEO effective January 1, 2027
Key Facts
Hydrofarm announced the appointment of Eric Cesari as chief executive officer effective January 1, 2027, succeeding William Toler, who will become executive chairman. The company said the change comes as it works to execute its operating priorities and return to profitability. Cesari currently serves as senior vice president of corporate development and international markets. His responsibilities include strategy, operations and international business. The company is therefore placing at its helm an executive who has previously been involved in its strategic initiatives and recapitalization.
Hydrofarm said Cesari has been with the company since 2018 and held senior strategic and leadership roles during that time. His contributions included acquisitions, international expansion and recapitalization, according to the company statement. His trajectory within the company points to a transition to one of its current executives rather than an outside appointment. He will take on the new role in early 2027, while Toler moves to the executive chairmanship. The changes follow a financial restructuring that included retiring the company's term loan.
Hydrofarm retired a $109 million term loan on October 27 that had been associated with annual debt service of about $12 million. As part of the recapitalization, former lenders received $27.5 million in convertible preferred stock, along with warrants to purchase 27.5 million common shares at an exercise price of $0.78 per share. The company raised about $8.3 million through a registered direct offering and concurrent private placement. It expected to have about 41.8 million common shares outstanding after the offering and conversion of the preferred stock. The terms show that addressing the loan burden also involved issuing equity instruments to lenders and raising new financing.
The new leadership faces a sharp downturn in operating activity: net sales in the third quarter of 2026 fell 50.7% to $14.5 million, compared with $29.4 million in the same period of 2025. The company attributed the decline to lower volume and mix, discontinuing certain distributed brands, exiting its Canadian business and working-capital constraints before the recapitalization. Gross margin, however, rose to 17.7% of sales from 11.6% a year earlier. The net loss narrowed to $7.8 million from $16.4 million. Adjusted EBITDA loss also improved to $1.1 million, compared with a loss of $4.4 million in the third quarter of 2025.
Hydrofarm set out the incoming CEO's priorities as executing the core business and returning to profitability, while investing in brands, the commercial sales channel, international markets, organic products and logistics. The direct commercial sales channel accounts for about one-third of the company's business, it said when announcing third-quarter results. The company had said it expected to move to positive adjusted EBITDA in the following year. On its listing, Hydrofarm announced on November 12 that it had regained compliance with Nasdaq's stockholders' equity requirement, following a letter dated November 9. The rule requires a minimum of $2.5 million, while the company said it was also monitoring the minimum bid-price requirement.
The leadership transition also includes another change in the senior management structure: the company said its president, Mark Parker, will leave on December 31, 2026. After his departure, Hydrofarm will eliminate the president role and distribute its responsibilities across the executive leadership team. This comes ahead of Cesari taking the CEO role the following day, according to the company's announced schedule. The company is thus combining an executive leadership transition with the elimination of the president role as part of a broader team reorganization. Returning to profitability and executing operating priorities remain among the tasks Hydrofarm has announced for the next phase.